Author

Wei Zhang

Observed institution: Boehringer Ingelheim (United States)

ORCID: 0000-0002-9697-8534

Observed ORCID: 0000-0002-9697-8534

OpenAlex ID: A5033844867

A Novel B7-H6–Targeted IgG-Like T Cell–Engaging Antibody for the Treatment of Gastrointestinal Tumors

2022 · Wei Zhang, Aurélie Auguste, et al. · Clinical Cancer Research · 21

Supplementary Figures S1-S4 from A Novel B7-H6–Targeted IgG-Like T Cell–Engaging Antibody for the Treatment of Gastrointestinal Tumors

2025 · Wei Zhang, Aurélie Auguste, et al.

Supplementary Figures S1-S4 from A Novel B7-H6–Targeted IgG-Like T Cell–Engaging Antibody for the Treatment of Gastrointestinal Tumors

2023 · Wei Zhang, Aurélie Auguste, et al.

Supplementary Figures S1-S4 from A Novel B7-H6–Targeted IgG-Like T Cell–Engaging Antibody for the Treatment of Gastrointestinal Tumors

2023 · Wei Zhang, Aurélie Auguste, et al.

Data from A Novel B7-H6–Targeted IgG-Like T Cell–Engaging Antibody for the Treatment of Gastrointestinal Tumors

2023 · Wei Zhang, Aurélie Auguste, et al.

Data from A Novel B7-H6–Targeted IgG-Like T Cell–Engaging Antibody for the Treatment of Gastrointestinal Tumors

2023 · Wei Zhang, Aurélie Auguste, et al.

Works count: 6

Citation count: 21

H-index: 1

I10-index: 1